
|Videos|October 7, 2022
Urology Times 50 Innovations Series: Intracavernosal injections for erectile dysfunction
Author(s)Urology Times staff
Joshua A. Broghammer, MD, discusses the development and use of intracavernosal injections for the treatment of patients with erectile dysfunction.
Advertisement
Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Joshua A. Broghammer, MD, discusses intracavernosal injections for the treatment of patients with erectile dysfunction. Broghammer is an associate professor of Urology at the University of Kansas Medical Center.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC
3
Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy
4
Permanent J code for mitomycin for intravesical solution now in effect
5

























































